Patents by Inventor Xiaoping Du

Xiaoping Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100260828
    Abstract: Methods and compositions for inhibition of platelet cell aggregation are described. In particular, compositions comprising cell permeant RGT peptides, such as RGT bound to a lipid moiety are provided. Compositions may be used in the treatment and prevention of clot related diseases such as stroke and myocardial infarction.
    Type: Application
    Filed: November 3, 2009
    Publication date: October 14, 2010
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Xiaoping Du, Xiaodong Xi
  • Publication number: 20090181057
    Abstract: The present invention is directed to compositions comprising inhibitors of GPIb-IX-VWF binding and methods of treating or preventing thrombosis associated with sepsis or endotoxemia in a mammal.
    Type: Application
    Filed: January 15, 2009
    Publication date: July 16, 2009
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventor: Xiaoping Du
  • Publication number: 20080293628
    Abstract: The present invention is directed to anti-platelet peptides that may be used in various methods for the treatment or prophylaxis of thrombosis. More specifically, the specification describes methods and compositions for making and using compositions GPIb? fragments as anti-platelet agents. The present invention is also directed to peptides that inhibit intracellular function of 14-3-3.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 27, 2008
    Inventors: Kesheng Dai, Xiaoping Du
  • Publication number: 20040087539
    Abstract: Methods of treating thrombotic and hemostatic conditions related to platelet activity are described herein. The methods of treating thrombotic and hemostatic conditions use active agents that modulate production of guanosine 3′, 5′ cyclic monophosphate (cGMP) or the function of cGMP-dependent protein kinase (PKG), and its downstream effectors, the ERK and p38 pathways.
    Type: Application
    Filed: December 12, 2003
    Publication date: May 6, 2004
    Inventor: Xiaoping Du